Latest Ranibizumab Stories
LONDON, March 26, 2015 /PRNewswire/ -- Report Details Analysis of revenues and R&D prospects for those eye drugs - you explore potentials What's the future
DALLAS, March 19, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Lucentis (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023" market research
RnRMarketResearch.com adds “Avastin (Macular Edema and Macular Degeneration) – Forecast and Market Analysis to 2023” to its store. Dallas, Texas (PRWEB)
SAN DIEGO, March 16, 2015 /PRNewswire/ -- Gensignia Life Sciences, Inc., (Gensignia) a molecular diagnostics company specializing in microRNA (miRNA) signatures as cancer diagnostic
RnRMarketResearch.com adds “Diabetic Macular Edema – Pipeline Review, H1 2015” report to its store.
USC Eye Institute studies show that prescription drug Ranibizumab may help reduce cases of blindness by 75 percent. Los Angeles, CA (PRWEB) February 18, 2015
In patients with moderate or worse vision loss at baseline, those treated with EYLEA gained, on average, an additional full line or more on an eye chart when compared to those treated with alternative
SAN DIEGO and LAKE FOREST, Ill., Feb. 10, 2015 /PRNewswire/ -- Pfenex Inc.
CRESTWOOD, Ky., Feb. 10, 2015 /PRNewswire/ -- Apellis Pharmaceuticals, Inc.
Blindness rates for common eye disease falling; macular degeneration treatments better than ever SAN FRANCISCO, Feb.
- Large; stout; burly.